Avelumab for treating metastatic Merkel cell carcinoma

  • Technology appraisal guidance
  • TA517
  • Published: 
  • Last updated: 
Download guidance (PDF)

Update information

April 2021: recommendation 1.2 was updated and replaced by avelumab for untreated Merkel cell carcinoma (NICE technology appraisal 691).

ISBN: 978-1-4731-2924-5